AI주식인사이트AI Stock Insight
B

원바이오젠

307280KOSDAQ의료용품 및 기타 의약 관련제품 제조업

65.8 / 100

Reference Date: 2026-06-10

Financial Score30.0 / 40
News Sentiment18.8 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 13.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Wonbiogen is a wound care dressing manufacturer specializing in foam and hydrocolloid dressings, supplying hospitals, pharmacies, and OTC markets. Market growth is driven by expanded health insurance coverage, aging population, changing perceptions of wound care, and increasing demand for aesthetic purposes.

Number of Employees

77people

Average Salary

0.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
6.70Industry Average 19.198.0Point

Half of industry avg (excellent)

PBR
1.04Industry Average 1.304.0Point

In line with industry avg

ROE
16.17Industry Average -4.893.5Point

Well below industry avg

Debt Ratio
1.15Industry Average 6.868.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.3% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲6.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 17.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position5.0Point

52w mid range (40%)

Current 6,250Won52-week high 8,25052-week low 4,875
1-month return1.0Point

1m -13.67% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral신탁계약해지결과보고서2026-06-09
  • Neutral분기보고서 (2026.03)2026-05-12